Alector market cap ALEC
Share price times shares outstanding: what the whole company sells for, since 2019.
- Today, Nov 2, 2026
- $240.1M
- Highest close in our data
- $2.9B
- Jul 2021
Alector is worth $240.1M at the close on Nov 2, 2026, at $2.15 a share.
That is up 72% over the last year and down 88% over five years.
Its highest close in our data was $2.9B in Jul 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $240.1M | $164.3M | $283.6M | +52% |
| 2025 | $158.3M | $91.2M | $336M | −9% |
| 2024 | $174.3M | $174.3M | $709.5M | −74% |
| 2023 | $671.4M | $362.6M | $813.8M | −12% |
| 2022 | $763.3M | $640.9M | $1.5B | −55% |
| 2021 | $1.7B | $1.2B | $2.9B | +40% |
| 2020 | $1.2B | $745.9M | $2.6B | −1% |
| 2019 | $1.2B | $990.1M | $1.4B | n/a |
Against its peers
Companies in Biotechnology nearest Alector's size, closest first, today.
| Company | Market cap |
|---|---|
| ALECAlector | $240.1M |
| PLXProtalix BioTherapeutics | $206.3M |
| MGTXMeiraGTx | $895.1M |
| VCELVericel | $2.1B |
| Peer median | $895.1M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Alector
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.